doi: 10.5732/cjc.010.10074

Advancement and prospects of tumor gene therapy

Chao Zhang, Qing-Tao Wang, He Liu, Zhen-Zhu Zhang, Wen-Lin Huang

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, P. R. China. wl_huang@hotmail.com.

[Abstract] Gene therapy is one of the most attractive fields in tumor therapy. In past decades, significant progress has been achieved. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. Several therapeutic strategies have evolved, including gene-based (tumor suppressor genes, suicide genes, antiangiogenic genes, cytokine and oxidative stress-based genes) and RNA-based (antisense oligonucleotides and RNA interference) approaches. In addition, immune response-based strategies (dendritic cell- and T cell-based therapy) are also under investigation in tumor gene therapy. This review highlights the progress and recent developments in gene delivery systems, therapeutic strategies, and possible clinical directions for gene therapy.

Chinese Journal of Cancer 2011, Volume: 30, Issue 3, Page: 182-188

[ PDF Full-text ]
[Google Scholar]

Cite this article

Chao Zhang, Qing-Tao Wang, He Liu, Zhen-Zhu Zhang, Wen-Lin Huang. Advancement and prospects of tumor gene therapy. Chin J Cancer. 2011, 30(3):182-188. doi:10.5732/cjc.010.10074


Export citations

EndNote